Allen Institute for Brain Science receives $8.7 million NIH grant to explore synapses

NewsGuard 100/100 Score

The Allen Institute for Brain Science, in a project led by Stephen Smith, Ph.D., Senior Investigator, has been awarded an $8.7 million, five-year Transformative Research Award from the National Institutes of Health (NIH) to lead the creation of a publicly accessible model of synapse populations in mouse and human brains. Synapses play a crucial role in many brain diseases and disorders, and the Open Synaptome Project that will be generated through this grant promises to change the way researchers approach the study of those diseases.

Transformative Research Awards from the NIH recognize projects that have the potential to drive major advances in biomedical and behavioral research with their novel approaches and broad impact.

"We are thrilled that the powerful combination of the Allen Institute's unique scientific approach with Stephen Smith's celebrated leadership in the neuroscience field is being recognized as having transformative potential by the NIH," says Allan Jones, CEO of the Allen Institute for Brain Science. "The consortium we will lead to study synapse diversity is poised to make important breakthroughs in how we think about the brain's function in both health and disease."

Synapses are the areas of connection and information transfer between individual neurons in the brain. A single neuron can have as many as ten thousand synapses, each of which is itself a complex signal-processing machine. Although many brain diseases and disorders are rooted in abnormalities of synapse populations, including neurotransmitter-related diseases like Parkinson's and major depression, their tiny size and highly complex nature have made synapses historically challenging to study, and the related diseases difficult to diagnose and treat.

"Synapses are exceptionally complex and extremely important to how the brain processes information, and no two synapses are quite alike," explains Smith. "Our grant will help illuminate that diversity—what we're calling the 'synaptome'—in order to shed much needed light onto the fundamental information processing mechanisms of mammalian brains."

Researchers on this grant are part of an international consortium that includes neurobiologists, biophysicists, clinicians, mathematicians and computer scientists. They will use powerful new imaging technologies to measure, analyze and model synapse populations in both mouse and human brains. A three-dimensional imaging technique pioneered by Smith during his tenure at Stanford University called array tomography will be used to study the complex protein expression at each synapse site.

The outcome of the project will be the Open Synaptome Project, in which the data and tools for the study's pipeline will be made publicly available for researchers around the world, enabling labs to more efficiently and effectively study synapse populations in other regions of the brain. Because the work funded by this grant will take place in both mouse and human brain samples, the resulting synaptome model will fuel our ability to translate knowledge from commonly used laboratory models into treatments for human disorders.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify the most harmful modifiable risk factors for dementia